Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-beta Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Qiao-Xin Li, Victor L Villemagne, James D Doecke, Alan Rembach, Shannon Sarros, Shiji Varghese, Amelia McGlade, Katrina M Laughton, Kelly K Pertile, Christopher J Fowler, Rebecca L Rumble, Brett O Trounson, Kevin Taddei, Stephanie R Rainey-Smith, Simon M Laws, Joanne S Robertson, Lisbeth A Evered, Brendan Silbert, Kathryn A Ellis, Christopher C Rowe Show all
Journal of Alzheimer's Disease | IOS PRESS | Published : 2015
Awarded by National Health and Medical Research Council (NHMRC) via the Dementia Collaborative Research Centres program
Awarded by NHMRC
Core funding for the study was provided by the Science and Industry Endowment Fund (http://www.sief.org.au) and CSIRO, which was supplemented by "in kind" contributions from the study partners (see www.aibl.csiro.au). The research was also supported by the National Health and Medical Research Council (NHMRC) via the Dementia Collaborative Research Centres program (DCRC2). The Mental Health Research Institute acknowledges the funding support from the Victorian government's Operational Infrastructure Support program. Alzheimer's Australia (Victoria and Western Australia) assisted with promotion of the study. VL Villemagne is supported by NHMRC Research Fellowship (#APP1046471). S Collins is supported in part by an NHMRC Practitioner Fellowship (#APP1005816).